Showing results (181-190 of 491) with videos related to

Sort By:
Pageof 50
American Heart Journal|February 26, 2008
Noninvasive, medical management for non-ST-elevation acute coronary syndromesMark Y Chan, Richard C Becker, Robert A Harrington, et al.
Annals of Internal Medicine|September 6, 2007
Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromesKeith A A Fox, Jean-Pierre Bassand, Shamir R Mehta, et al.
Heart (British Cardiac Society)|April 20, 2006
Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trialP A Poole-Wilson, S J Pocock, K A A Fox, et al.
Nature Medicine|February 16, 2024
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trialJeffrey I Weitz, László B Tankó, Jürgen Floege, et al.
European Heart Journal|August 12, 2003
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)Keith A A Fox, Shaun G Goodman, Frederick A Anderson, et al.
Plos Medicine|March 7, 2018
Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohortMarlous Hall, Tatendashe B Dondo, Andrew T Yan, et al.
European Heart Journal|January 17, 2009
Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary EventsPh Gabriel Steg, Keith A A Fox, Kim A Eagle, et al.
European Heart Journal|September 30, 2008
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE studySanjit S Jolly, Janice Pogue, Kimberly Haladyn, et al.
JAMA|June 16, 2005
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trialsShamir R Mehta, Christopher P Cannon, Keith A A Fox, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2022
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA RegistryKeith A A Fox, Victor Aboyans, E Sebastian Debus, et al.
Pageof 50